PNC-27 (10mg) Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂ (lactam bridge Asp-Lys)

Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂ (lactam bridge Asp-Lys)

prolonged slow-wave sleep (SWS) duration

IL-6) in white adipose tissue and exhibited mild anti-inflammatory effects linked to decreased macrophage infiltration

ARA-290 administration significantly reduced pain scores (measured by NRS and NTSS-6)

reduction in inflammatory infiltrates

PNC-27 (10mg) Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂ (lactam bridge Asp-Lys)PNC 27 Overview PNC 27 is a synthetic peptide engineered to selectively target and induce necrosis in cancer cells while leaving healthy, normal cells unaffected. Comprising 32 amino acids, PNC 27 belongs to the PNC family of investigational proteins and is designated exclusively for research purposes. It functions by binding to HDM 2, a protein overexpressed in the membranes of cancer cells, where it triggers transmembrane pore formation, resulting